全文获取类型
收费全文 | 20953篇 |
免费 | 1548篇 |
国内免费 | 625篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 307篇 |
妇产科学 | 50篇 |
基础医学 | 1271篇 |
口腔科学 | 20篇 |
临床医学 | 2142篇 |
内科学 | 3966篇 |
皮肤病学 | 79篇 |
神经病学 | 226篇 |
特种医学 | 395篇 |
外科学 | 3129篇 |
综合类 | 4888篇 |
现状与发展 | 4篇 |
预防医学 | 817篇 |
眼科学 | 947篇 |
药学 | 2340篇 |
18篇 | |
中国医学 | 2450篇 |
肿瘤学 | 42篇 |
出版年
2024年 | 26篇 |
2023年 | 281篇 |
2022年 | 535篇 |
2021年 | 927篇 |
2020年 | 733篇 |
2019年 | 574篇 |
2018年 | 628篇 |
2017年 | 672篇 |
2016年 | 738篇 |
2015年 | 859篇 |
2014年 | 1732篇 |
2013年 | 1562篇 |
2012年 | 1689篇 |
2011年 | 1768篇 |
2010年 | 1278篇 |
2009年 | 1154篇 |
2008年 | 1165篇 |
2007年 | 1036篇 |
2006年 | 921篇 |
2005年 | 791篇 |
2004年 | 595篇 |
2003年 | 528篇 |
2002年 | 391篇 |
2001年 | 378篇 |
2000年 | 267篇 |
1999年 | 193篇 |
1998年 | 156篇 |
1997年 | 166篇 |
1996年 | 134篇 |
1995年 | 151篇 |
1994年 | 131篇 |
1993年 | 134篇 |
1992年 | 112篇 |
1991年 | 62篇 |
1990年 | 82篇 |
1989年 | 80篇 |
1988年 | 88篇 |
1987年 | 60篇 |
1986年 | 55篇 |
1985年 | 64篇 |
1984年 | 40篇 |
1983年 | 13篇 |
1982年 | 29篇 |
1981年 | 20篇 |
1980年 | 18篇 |
1979年 | 20篇 |
1978年 | 18篇 |
1976年 | 11篇 |
1973年 | 11篇 |
1969年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 基于临床信息系统分析总结真实世界的数据,采用数据挖掘的方法探讨中医药治疗糖尿病肾病的用药规律。方法 收集2018年1月-2020年12月上海中医药大学附属曙光医院宝山分院健康信息系统确诊的糖尿病肾病的门诊或住院患者的诊疗信息,建立Excel数据库,采用Excel 2010软件统计高频药物的四气、五味、归经及功效;使用SPSS Modeler 18.0软件中的Apriori算法分析关联规则,采用web节点建构药对关联网状图;运用SPSS 25统计软件进行因子分析。结果 本研究最终纳入477例接受中药饮片治疗的DKD患者,在1203条方剂信息中,涉及中药462种;使用频数排名前5位的中药分别是黄芪、黄精、石斛、山茱萸、麦冬;使用频数前5类的中药类别分别是补气药、补阴药、清热燥湿药、活血调经药、息风止痉药;在30味高频药物中,苦、甘、辛药味最为常见;药性寒、温数量接近;归脾经、肝经、肺经、肾经居多;关联规则提示,药物组合中置信度最高的组合为地龙-当归-僵蚕,因子分析共得到5个有效因子,累积贡献率为47.33%。结论 中医药治疗DKD在补益气血阴阳的同时,兼顾对瘀血、湿邪和痰饮的治疗,结合证型,可考虑使用黄芪、黄精、石斛、山茱萸、麦冬、金蝉花等药物的使用,清热燥湿药物如黄连、黄芩、黄柏可适当加入,为使邪有去处,大黄、车前子或可增添疗效。 相似文献
3.
4.
5.
Diabetic foot ulcer is a devastating complication of diabetes mellitus and significant cause of mortality and morbidity all over the world and can be complex and costly. The development of foot ulcer in a diabetic patient has been estimated to be 19%-34% through their lifetime. The pathophysiology of diabetic foot ulcer consist of neuropathy, trauma and, in many patients, additional peripheral arterial disease. In particular, diabetic neuropathy leads to foot deformity, callus formation, and insensitivity to trauma or pressure. The standard algorithms in diabetic foot ulcer management include assessing the ulcer grade classification, surgical debridement, dressing to facilitate wound healing, off-loading, vascular assessment (status and presence of a chance for interventional vascular correction), and infection and glycemic control. Although especially surgical procedures are sometimes inevitable, they are poor predictive factors for the prognosis of diabetic foot ulcer. Different novel treatment modalities such as nonsurgical debridement agents, oxygen therapies, and negative pressure wound therapy, topical drugs, cellular bioproducts, human growth factors, energy-based therapies, and systematic therapies have been available for patients with diabetic foot ulcer. However, it is uncertain whether they are effective in terms of promoting wound healing related with a limited number of randomized controlled trials. This review aims at evaluating diabetic foot ulcer with regard to all aspects. We will also focus on conventional and novel adjunctive therapy in diabetic foot management. 相似文献
6.
7.
8.
Hisham F. Bahmad Robert Poppiti John Alexis 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(2):487-491
Background and aimsDiabetes mellitus (DM) is a chronic metabolic disease associated with long-term multisystem complications, among which nonhealing diabetic foot ulcers (DFUs) are recognized as major cause of morbidity and mortality. Treating DFUs with surgical procedures such as synthetic or biological skin grafts or skin substitutes has several limitations, where none of the currently available skin substitutes is ideal.MethodsOVID/Medline and PubMed databases were searched using the Medical Subject Heading (MeSH) or Title/Abstract words (“diabetic foot ulcers”, “skin substitutes”, and “nanofibers”), to identify published research studies on DFUs and nanofibers.ResultsElectrospinning nanotechnology is being used in the biomedical field to produce polymeric nanofibers impregnated with drugs for wound healing, burns and diabetic ulcers. Those nanofibers also enable seeding of cells into them and culturing them in vitro to synthesize tissue-like structures. Knowing the advantages of generating patient-specific induced pluripotent stem cells (iPSCs) and organoids in three-dimension (3D), including skin organoids, it is worth mingling these technologies to develop tissue-engineered biological skin substitutes.ConclusionNanofiber-skin substitutes hold promise for treatment of patients suffering from DFUs and inspire novel strategies that could be applied to other organ systems as well, introducing a new era of “regenerative and personalized medicine”. 相似文献
9.
10.
Sarah J. Schrauben Haochang Shou Xiaoming Zhang Amanda Hyre Anderson Joseph V. Bonventre Jing Chen Steven Coca Susan L. Furth Jason H. Greenberg Orlando M. Gutierrez Joachim H. Ix James P. Lash Chirag R. Parikh Casey M. Rebholz Venkata Sabbisetti Mark J. Sarnak Michael G. Shlipak Sushrut S. Waikar Paul L. Kimmel Ramachandran S. Vasan Harold I. Feldman Jeffrey R. Schelling 《Journal of the American Society of Nephrology : JASN》2021,32(1):115